PURPOSE. Mutations in SLC4A11, a member of the SLC4 superfamily of bicarbonate transporters, give rise to corneal endothelial cell dystrophies. SLC4A11 is a putative Na RESULTS. SLC4A11 is localized to the basolateral membrane in BCEC. B(OH) 4 À (2.5-10 mM) in bicarbonate-free Ringer induced a rapid small acidification (0.01 pH unit) followed by alkalinization (0.05-0.1 pH unit), consistent with diffusion of boric acid into the cell followed by B(OH) 4 À . However, the rate of B(OH) 4
PURPOSE. Mutations in SLC4A11, a member of the SLC4 superfamily of bicarbonate transporters, give rise to corneal endothelial cell dystrophies. SLC4A11 is a putative Na RESULTS. SLC4A11 is localized to the basolateral membrane in BCEC. B(OH) 4 À (2.5-10 mM) in bicarbonate-free Ringer induced a rapid small acidification (0.01 pH unit) followed by alkalinization (0.05-0.1 pH unit), consistent with diffusion of boric acid into the cell followed by B(OH) 4 À . However, the rate of B(OH) 4 À -induced pH i change was unaffected by overexpression of SLC4A11. B(OH) 4 À did not induce significant changes in resting [Na þ i ] or the amplitude and rate of acidification caused by Na þ removal. siRNA-mediated knockdown of SLC4A11 (~70%) did not alter pH i responses to CO 2 /HCO 3 À -rich Ringer, Na þ -free induced acidification, or the rate of Na þ influx in the presence of bicarbonate. However, in the absence of bicarbonate, siSLC4A11 knockdown significantly decreased the rate (43%) and amplitude (48%) of acidification due to Na þ removal and recovery (53%) upon add-back. Additionally, the rate of acid recovery following NH 4 þ prepulse was decreased significantly (27%) by SLC4A11 silencing.
CONCLUSIONS. In corneal endothelium, SLC4A11 displays robust Na þ -coupled OH À transport, but does not transport B(OH) 4 À or HCO 3 À .
Keywords: SLC4A11, intracellular pH, intracellular Na þ , bicarbonate/borate transport T he corneal endothelium is a confluent monolayer of thin (4 lm) wide (diameter: 20-30 lm) cells on the posterior surface of the cornea that function to regulate the hydration and optical transparency of the cornea through active iontransport processes. 1 Ion-transport dysfunction through trauma, inflammation, toxicity, or endothelial dystrophy leads to corneal edema, loss of transparency, and poor vision. For example, Fuchs' endothelial corneal dystrophy (FECD), congenital hereditary endothelial dystrophy (CHED), and Harboyan Syndrome (HS) are characterized by bilateral loss of vision, decreased endothelial cell density, and abnormal Descemet's membrane. Because of the nonregenerative nature of the corneal endothelium and lack of specific pharmacologic remedy, corneal transplantation is the only current successful therapeutic strategy for restoring corneal transparency. 2, 3 Mutations in SLC4A11, 4-10 COL8A2, 11-14 TCF8, 15, 16 or LOXHD1
17 genes are associated with endothelial dystrophies. These genes encode a novel anion-transporter, a Descemet's membrane component secreted by the endothelium, a transcription factor associated with embryonic epithelial development, and a stereociliary protein, respectively. Although different hypotheses have been suggested, the pathophysiology of these dystrophies has not been fully delineated. SLC4A11 is a ubiquitously expressing gene that encodes a 100-kDa protein with 14 transmembrane domains, 18, 19 assembling as dimers within the plasma membrane. 20 In the eye, it is expressed in the corneal epithelium and endothelium. 21 Because of its membership in the Solute Carrier 4 (SLC4) superfamily, SLC4A11 was assumed to be a bicarbonate transporter. 19 The only functional investigation, however, suggests that SLC4A11 does not transport bicarbonate, but is a Na transporter in corneal endothelium could compromise the endothelial pump. Although the biological significance of putative B(OH) 4 À transport in animal cells is unknown, the potential presence in the eye is intriguing. Therefore, using overexpression and small interfering RNA (siRNA) knockdown approaches in cultured primary bovine corneal endothelial cells (BCECs), we examined the role of SLC4A11 as a potential HCO 3 À or B(OH) 4 À transporter. In addition, we tested whether SLC4A11 is a Na þ :OH À cotransporter in BCECs. Determination of the function of SLC4A11 in the corneal endothelium will provide important information for understanding the pathology of SLC4A11 mutations in endothelial dystrophies.
MATERIALS AND METHODS

BCEC Primary Cultures and Other Cell Type
All experiments, except where indicated, were carried out using BCECs obtained as described previously. 28 Briefly, corneas were isolated from bovine eyes procured from a local slaughterhouse and placed in concave molds with posterior surface facing upward. Endothelial cells were detached from the surface after incubation with 0.25% trypsin at 378C for 15 minutes and gentle scraping. The cells were dispersed in Dulbecco's modified Eagle's medium (DMEM) containing 10% bovine calf serum and 1% penicillin (100 U/mL)/fungizone (0.25 lg/mL) mixture in T-25 flasks at 378C with 5% CO 2 until confluent, 5 to 7 days. Cells (3.5 3 10 5 ) were subcultured into six-well plates or six 25-mm coverslips for experiments, allowed to come to 100% confluence, and used within 24 to 48 hours. Rabbit eyes (Pel-Freez Biologicals, Roger, AR) were used to obtain corneas from which the endothelial layers from the posterior side were peeled using pointed forceps to obtain native rabbit corneal endothelium. Human corneal endothelial cells (HCECs) were cultured as described previously. 29 
Semiquantitative PCR
Total RNA extracted from confluent BCEC cultures (TRIzol method; Life Technologies Corp., Carlsbad, CA) was reverse transcribed and probed for mRNA expression of SLC4A11 with specific primers (SuperScript III One-Step RT-PCR system Platinum Taq DNA polymerase kit; Invitrogen, Carlsbad, CA). Primer sequences were designed based on bovine and rabbit SLC4A11 mRNA sequences (Bovine, 
SDS-PAGE and Western Blotting
BCECs grown on six-well plates were rinsed with chilled PBS and total protein extracted using RIPA lysis buffer containing protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). The extract was sonicated and centrifuged (13,000g for 20 minutes) and the supernatant was analyzed for protein content (Pierce BCA Protein Assay Kit; Thermo Scientific, Rockford, IL). Protein (20-30 lg) in 53 sample buffer was resolved on 9% SDS gels and transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). Blots were then blocked with 5% nonfat milk and probed with a custom SLC4A11 antibody (raised against the C-terminal region: IIEAKYLDVMDAEH; Covance, Richmond, CA), 1:1000 dilution, overnight followed by antirabbit secondary antibody conjugated to horseradish peroxidase for 1 hour and developed (Pierce Supersignal West Pico Chemiluminescent substrate; Thermo Scientific). Blots were subjected to densitometric analysis using UN-SCAN-IT 6.1. b-Actin was also probed each time to ensure equal protein loading. Purified SLC4A11 custom antibody was tested by Western blot. The band obtained using the custom antibody was at the predicted size and the predicted band was absent when the antigen peptide was included with the sample.
Immunofluorescence Staining
BCECs grown on coverslips were fixed and prepared for staining as described previously. 30 Cells were incubated overnight with antirabbit SLC4A11 (1:50) and antimouse ZO-1 (Zonula Occludens 1:30; Invitrogen) followed by washing and secondary antibody treatment for 1 hour (antirabbit Alexa 488 and antimouse Alexa 635; Molecular Probes, Eugene, OR). The coverslips were mounted on glass slides using commercial mounting media (Prolong; Molecular Probes) containing DAPI.
Physiologic Measurement of Intracellular pH and Na þ Concentration
Measurement protocol and system design were similar to those of previous studies. 31, 32 Briefly, BCECs grown to 100% confluence on 25-mm coverslips were loaded with BCECF-AM (10 lM) or SBFI-AM (10 lM) (Molecular Probes), pH, and Na 4 À containing Ringer's solution was prepared by dissolving boric acid and adjusting pH with NaOH. Na þ -free Ringer's solution contained NMDG-Cl or tetramethyl ammonium chloride (TMA)-Cl (for borate experiments) as a Na þ substitute. All Ringer's solutions were equilibrated with air bubbled through NaOH (BF) or 5% CO 2 (BR) and pH was adjusted to 7.50 with NaOH or Tris base at 378C. Osmolarities of all solutions were adjusted to 295 to 300 mOsM by adding sucrose. 5-(N-Ethyl-N-isopropyl) amiloride (EIPA; Sigma-Aldrich, St. Louis, MO) was added to the Ringer's solution on the day of the experiment.
The cells were excited at 440 and 495 nm for BCECF and 340 and 380 nm for SBFI fluorescence. The ratio of emitted fluorescence (520-550 nm for BCECF and above 450 nm for SBFI) was obtained at 1 Hz. BCECF ratios were calibrated against pH i by the high-K þ -nigericin technique as described previously. 31, 32 Relative changes in [Na i ] were expressed as the fluorescence ratio 340/380 or change in fluorescence ratio (DF/F).
Overexpression of SLC4A11
Cells grown on six-well plates or 25-mm coverslips were transfected with human influenza hemagglutinin (HA)-tagged hSLC4A11 containing phCMV2 vector or phCMV2 empty vector 5 Mouse monoclonal anti-HA antibody, 1:5000 dilution (AB-3212; Santa Cruz Biotechnology, Santa Cruz, CA).
Membrane Protein Expression of SLC4A11
BCECs grown in T-75 flasks were transfected with HA-tagged hSLC4A11 containing phCMV2 vector or empty vector as described above. Cells were processed for extraction of membrane proteins 48 hours posttransfection using surface biotinylation according to the manufacturer's directions (89881; Pierce Biotechnology, Rockford, IL). Briefly, cells were treated with 0.1 mg/mL Sulfo-NHS-SS-Biotin in PBS at 48C for 30 minutes, collected using a cell scraper, lysed in the presence of protease inhibitors, centrifuged, supernatant applied to a commercial column (NeutrAvidin Agarose Resin; Thermo Scientific) for 1 hour, and centrifuged to collect the unbound flow through. The column was washed and bound protein eluted with sample buffer containing DTT (bound fraction of the lysate). Membrane expression was tested by Western blot using both anti-HA-tag and anti-SLC4A11 antibodies in both membrane bound and unbound fractions of the lysate as well as total lysate. Equal amounts of total, bound, and unbound protein fractions were analyzed by SDS-PAGE. 
Measurement of Borate Concentration and Effect on Cell Viability
Borate concentration in media was estimated by a colorimetric assay using azomethine-H. 33 Samples were concentrated 23 by vacuum centrifugation to ensure measurable boron concentrations as low as 0.1 lM. Boron was depleted in the media with and without serum using a boron-specific ionic exchange resin (Amberlite IRA-743; Sigma-Aldrich). The UVsterilized resin (Amberlite, 0.6 g per 50 mL of medium; SigmaAldrich) was added to the medium and agitated on a rotator at 80 rpm for 24 hours at 48C. The treatment was repeated with a fresh batch of exchange resin for the next 24 hours. Medium was collected and filtered before use. The [borate] of DMEM þ serum was 25 lM, which was reduced to <10 lM by resin treatment. The effect of borate on cell growth and viability was measured by MTT assay. BCECs or HEK293 cells were seeded on 24-well plates and incubated with borate-depleted medium alone or supplemented with different concentrations of borate for 24 to 48 hours. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) was added to a final concentration of 0.45 mg/mL and incubated 1 hour at 378C. Insoluble formazan (converted from MTT by mitochondrial reductases) was solubilized with 500 lL DMSO. Absorbance was read at 540 nm in a microplate reader. 
Statistical Analysis
Statistical significance was determined using Student's t-test. A value of P < 0.05 was considered significant. Histogram data are presented as mean values 6 SE.
RESULTS
Expression of SLC4A11 mRNA was determined in both cultured BCECs and native rabbit corneal endothelium, the two commonly used models for investigating physiologic function of the corneal endothelium. RT-PCR using multiple sets of genome specific primers for SLC4A11 yielded single bands with the expected product size (Figs. 1A, 1B) . b-Actin was used as a control for all PCR protocols. Figure 1C is a Western blot showing a SLC4A11-specific band at approximately 100 kD, consistent with previous reports, 19,21 obtained using cultured (BCECs and HCECs) and native (bovine and rabbit) corneal endothelium protein extracts. SLC4A11 immunostaining in BCECs ( Fig. 2A) and fresh rabbit corneal endothelium (Fig. 2B) showed predominant lateral membrane localization. Rabbit cells more clearly showed the lateral localization of SLC4A11, consistent with a previous report. 22 Although peripheral staining was evident in cultured BCECs, the staining was not confined to the membrane in some areas, probably due to less specific antibody binding in the cultured cells.
Using SLC4A11-transfected HEK293 cells Park and colleagues 22 suggest that SLC4A11 cotransports Na þ :B(OH) 4 À or Na þ coupled to OH À in the absence of borate. To test Na þ :B(OH) 4 À as a substrate for SLC4A11 in corneal endothelium, BCECs loaded with the pH-sensitive dye BCECF were perfused with 2.5 and 10 mM B(OH) 4 À in BF Ringer's solution. Figure 3A shows that B(OH) 4 À induced a small but brief acidification (~0.01 pH units), followed by a small alkalinization (þ0.06 and þ0.11 pH units with 2.5, n ¼ 12; and 10 mM
The inset in Figure 3A shows reversal after removal of B(OH) 4 
À
. Figure 3B summarizes the pH i changes due to B(OH) 4 À . To determine if this boratedependent alkalinization represents SLC4A11-mediated Na þ :B(OH) 4 À transport we overexpressed SLC4A11 in BCEC (Fig. 3C) . Membrane expression of the induced protein was ascertained by Western blot of the isolated membrane fraction by surface biotinylation (Fig. 3D) . HA-tagged protein was found in the bound fraction confirming membrane localization of the overexpressed SLC4A11. The unbound fraction had a very faint band for SLC4A11, indicative of relatively low cytosolic retention of the overexpressed protein. Figure 3E shows that BCECs overexpressing SLC4A11 did not show any difference in the rate (and amplitude) of B(OH) 4 À -induced alkalinization compared with untransfected cells in response to 10 mM B(OH) 4 À . The primary evidence for Na þ :B(OH) 4 À cotransport was the acceleration of Na þ -free induced acidification in the presence of B(OH) 4 À . 22 In that study the Na þ /H þ exchanger (NHE1) was blocked by the amiloride analog EIPA, to magnify the effect. The optimum effective dose of EIPA in BCEC was estimated by determining inhibition of the initial rate of pH i recovery from acid load induced by an NH 4 þ pulse. We found that 0.25 lM EIPA produced an approximately 70% to 80% decrease in initial rate of recovery (data not shown). Higher concentrations showed cell toxicity. Therefore, the following experiment was performed in the presence of 0.25 lM EIPA. Figure 4A shows BCEC acidification following removal of Na þ in the absence and then in the presence of 5 mM B(OH) 4 À . Figures 4B and 4C summarize the data and show that the rate and amplitude of acidification following removal of Na þ did not change significantly in the presence of 5 mM B(OH) 4 À compared with control.
Ion Transport Function of SLC4A11 in CE
We further examined potential Na þ -coupled B(OH) 4 À transport by measuring [Na (Fig.  5A, inset) . Figure 5A shows no change in SBFI fluorescence upon addition of B(OH) 4 À in control BCEC, indicating no significant Na-linked B(OH) 4 À transport by cells endogenously expressing SLC4A11. Figure 5B shows that overexpression of SLC4A11 also did not alter the response to B(OH) 4 À . The previously reported results (Figs. 3-5) are consistent with the absence of Na þ -dependent B(OH) 4 À transport by SLC4A11. Moreover, since putative B(OH) 4 À transport by SLC4A11 appeared to have effects on cell proliferation and survival, 22 we examined the effect of borate on BCEC cell survival. Borate (10-300 lM; physiologic concentrations of borate are generally <100 lM 34 ) had no significant effect on endothelial cell proliferation or survival (see Supplementary Fig. S1 ).
SLC4A11, a new addition to the SLC4 superfamily of bicarbonate transporters has not been thoroughly tested for possible HCO 3 À transport. Three different experiments were conducted to test possible Na þ -coupled HCO 3 À transport by SLC4A11 in BCECs transfected with siSLC4A11. Figure 6 shows that transfection with siSLC4A11 in BCECs caused an approximately 70% decrease in SLC4A11 expression between 48-and 72-hour posttransfection. First, the effect of SLC4A11 knockdown on CO 2 /HCO 3 À -induced changes in pH i was determined. Figure 7A shows that in control cells a typical CO 2 /HCO 3 À response includes slight acidification due to CO 2 influx followed by alkalinization due to Na þ :HCO 3 À influx that is persistent in the presence of CO 2 /HCO 3 À . Contribution of SLC4A11 to the net bicarbonate transport should be indicated by a decrease in the rate and amplitude of alkalinization in siSLC4A11-transfected cells. Figure 7B shows a response similar to control in siSLC4A11-transfected cells. Figures 7C,  7D summarize the rate and amplitude of alkalinization, respectively, indicating no significant difference due to Figure 8C summarizes the data from different trials and shows that the rate of Na þ influx was not significantly different between the control and the transfected. Third, the effect of siSLC4A11 knockdown on Na þ -free induced acidification in the presence of CO 2 /HCO 3 À was measured. In siSLC4A11-transfected cells the rate and amplitude of acidification and the rate of recovery should be reduced if SLC4A11 has Na Figures 9C and 9D summarize the results from different trials and indicate that the rate and amplitude of acidification and the rate of recovery in the presence of CO 2 /HCO 3 À was not significantly different between control and transfected cells. In summary, these results indicate that SLC4A11 does not produce any measurable Na þ :HCO 3 À transport in BCECs. Finally, we examined the potential for SLC4A11 to act as a Na þ :OH À cotransporter, as suggested in a previous study. 22 To test this hypothesis, pH i was measured during a Na þ -free pulse in the absence of bicarbonate. Figures 10A and 10B show representative pH i traces from control and siSLC4A11-transfected cells. Figures 10C-E summarize the data and indicate that the rate and amplitude of acidification was reduced by 43% and 48% (P ¼ 0.02 and 0.0006, respectively) and the rate of recovery, following Na þ add-back, was reduced by 53% (P ¼ 0.04) in the transfected cells. We further confirmed this activity by measuring the rates of recovery from an acid load induced by a 1-minute pulse of 20 mM NH 4 Cl in the absence of bicarbonate. Cells exposed to NH 4 Cl solutions first alkalinize due to inward diffusion of NH 3 , followed by a slower acidification due to NH 4 þ uptake. Removal of NH 4 Cl causes rapid NH 3 efflux, trapping protons, and acidifying the cells. Figures 11A and 11B show representative traces from control and transfected cells and indicate a slowing of acid recovery in siSLC4A11-treated cells. Figure 11C summarizes these results and shows that knockdown of SLC4A11 significantly decreased the rate of recovery (~30%) from an acid load (P ¼ 0.007).
DISCUSSION
Putative B(OH) 4 À transport by SLC4A11 was intriguing since B(OH) 4 À appeared to have effects on cell proliferation and survival. 22 However, we could find no evidence for B(OH) 4 À transport in BCECs or an effect of borate on cell survival ( Supplementary Fig. S1 ). HCO 3 À transport has an important role in endothelial function. However, from the results of the current study we can say that SLC4A11 does not provide significant HCO 3 À transport, consistent with an earlier report. 22 Finally, we confirmed that SLC4A11 does have Na þ -dependent OH À cotransport activity. 22 This functions similar to the Na þ /H þ exchange (NHE1), which would regulate pH i , and could facilitate lactic acid flux across the endothelium. 35, 36 SLC4A11 is considered a human homolog of the plant B(OH) 4 À transporter (AtBor1) and is suggested to transport B(OH) 4 À coupled to Na þ based on a significant B(OH) 4 À -dependent increase in the rate of acidification under Na þ -free conditions in SLC4A11-transfected HEK293 cells. 22 That study however, is problematic because the Na þ substitute used, Nmethyl-D-glucamine (NMDG þ ), is a borate chelator (forms a 1:1 complex with B[OH] 4 À ). [37] [38] [39] NMDG would deplete the available borate in the solutions and the acidification due to Na þ removal in the presence of B(OH) 4 À cannot be attributed to Na þ :B(OH) 4 À transport. Moreover, the chelation of borate leads to deprotonation of boric acid, thereby acidifying the solutions, which may explain the faster rate of acidification. Our experiments substituted Na þ with equimolar amounts of TMA (Fig. 4) . Under these conditions, we did not find any B(OH) 4 À -dependent Na þ fluxes. Moreover, overexpression of SLC4A11 did not alter the pH i response to 2.5 or 10 mM B(OH) 4 À (Fig. 3E) . Consistent with these findings, [Na (Fig. 8) . From these experiments we conclude that SLC4A11 does not possess significant Na þ -dependent HCO 3 À cotransport activity consistent with results from Park and colleagues, 22 who found that SLC4A11 provides Na þ :OH À permeability in the absence of bicarbonate and borate. We tested this activity by determining the rate of pH i changes induced by extracellular Na þ depletion and add-back and from an acid load induced by NH 4 þ pulse in the absence of HCO 3 À . We found that the rate and extent of acidification caused by Na þ depletion were reduced significantly as well as the rate of recovery on Na þ add-back in siSLC4A11-treated cells (Fig. 10) . These results strongly suggest SLC4A11 contributes to the Na þ -free acidification and recovery upon add-back. In addition, the rate of recovery from an NH 4 þ pulse induced acid load was also significantly reduced due to SLC4A11 knockdown (Fig. 11) . These findings confirm that SLC4A11 is transporting Na þ coupled to OH À contributing to pH i regulation in corneal endothelium.
SLC4A11 is associated with the pathology of late-onset FECD, 4, 6 early-onset CHED2, 5, 7, 8, 41, 42 and Harboyan Syndrome. 9, 10 The role of SLC4A11 in these endothelial dystrophies is supported by the loss of function due to low levels of protein indicated by retention of SLC4A11 mutants and the wild type (in the case of heterozygous dominant FECD) in the ER 4,5 along with reduced levels of SLC4A11 in FECD corneal endothelium. 27 Loss of functional SLC4A11 could be a causative factor for low endothelial cell density due to apoptosis [43] [44] [45] implicated in these dystrophies. Similar to NHE1 as a pH i modulator, SLC4A11 may regulate cell survival through antiapoptotic mechanisms. 46, 47 On the other hand, impaired SLC4A11 expression could lead to compromised pH i regulation affecting HCO 3 À and lactic acid transport and depressing endothelial pump function characteristic of these dystrophies. Consistent with this hypothesis, SLC4A11 knockout mice present corneal edema and accumulation of NaCl in the stroma. 48 Further studies are needed to determine if mutational loss of this functional activity or other secondary effects (e.g., stress induced by UPR) contribute to corneal edema and subsequent loss of endothelial cells. However, mutations in genes other than SLC4A11 (e.g., COL8A2), where a mutant knock-in model depicted phenotypes associated with FECD suggest multiple pathologic mechanisms for the development of these dystrophies.
In summary, SLC4A11 is a basolateral membrane protein in corneal endothelial cells. Functional characterization revealed that SLC4A11 acts as a Na þ -dependent pH i modulator transporting OH À with no significant affinity to B(OH) 4 À or HCO 3 À anions.
